IP Library › Granted Patent US 12,357,282
Granted Patent B2
US 12,357,282 · App. 17/776,386 · Granted Jul 15, 2025

Interstitial fluid removal device

Inventors: Alexandre Charles Roger Motta (Rotterdam, NL); Varsha Sakina Thakoersing (Rotterdam, NL); Richardus Paulus Anton Oranje (Rotterdam, NL)
Assignee: IMCOMET B.V.
A61B10/0045A61M5/3295A61B2010/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,282
App. No.
17/776,386
Granted
Jul 15, 2025
Kind
B2
Abstract

An interstitial fluid removal device including a first needle, a second needle, a fluid injector and an interstitial fluid extractor. The first needle is configured for insertion in a tissue of a multicellular organism to provide a fluid inlet channel. The second needle is configured for insertion in a tissue of a multicellular organism to provide an interstitial fluid outlet channel. The fluid injector is arranged in fluid communication with both a fluid source and the first needle and configured to inject a fluid in the tissue of the multicellular organism. The fluid extractor is arranged in fluid communication with the second needle and configured to extract interstitial fluid from the tissue of the multicellular organism. The fluid injector and the fluid extractor are independently and/or simultaneously operable with respect to each other.

Claims (40)

1. An interstitial fluid removal device comprising a first needle, a second needle, a fluid injector and an interstitial fluid extractor,

the first needle being configured for insertion in a tissue of a multicellular organism to provide a fluid inlet channel;

the second needle being configured for insertion in a tissue of a multicellular organism to provide an interstitial fluid outlet channel;

the fluid injector being arranged in fluid communication with both a fluid source and the first needle and configured to inject a fluid in the tissue of the multicellular organism;

the interstitial fluid extractor being arranged in fluid communication with the second needle and configured to extract interstitial fluid from the tissue of the multicellular organism,

wherein the fluid injector and the interstitial fluid extractor are independently operable with respect to each other,

wherein a distance between a needle tip of the first needle and a needle tip of the second needle is smaller than 3 mm, and

wherein an opening of the needle tip of the first needle and an opening of the needle tip of the second needle face towards each other.

2. The interstitial fluid removal device according to claim 1 , wherein a penetration depth of the first needle is larger than a penetration depth of the second needle.

3. The interstitial fluid removal device according to claim 1 , wherein the second needle is configured for insertion in the tissue of the multicellular organism perpendicular with respect to a surface defined by said tissue.

4. The interstitial fluid removal device according to claim 1 , wherein the first needle is configured for insertion in the tissue of the multicellular organism at an angle of between 20° and 70° with respect to the second needle.

5. The interstitial fluid removal device according to claim 1 , wherein the second needle is configured to be at least partially extracted from said tissue after insertion therein and before the fluid extractor is operated.

6. The interstitial fluid removal device according to claim 1 , wherein said distance between the needle tip of the first needle and the needle tip of the second needle is smaller than 2 mm.

7. The interstitial fluid removal device according to claim 1 , wherein the distance between the needle tip of the first needle and the needle tip of the second needle is larger than 0.01 mm.

8. The interstitial fluid removal device according to claim 1 , wherein the first needle and the second needle are configured for insertion in a skin of an animal.

9. The interstitial fluid removal device according to claim 1 , further comprising a housing for receiving a needle pair, wherein said first needle and said second needle forms said needle pair.

10. The interstitial fluid removal device according to claim 1 , wherein the fluid is selected from the group consisting of surface tension modifiers, osmolality modifiers, pH modifiers, chelating agents, and bio-active molecules.

11. The interstitial fluid removal device according to claim 1 , wherein the fluid injector has a flow rate of at least 6 μl/h.

12. A method for treating a subject with skin tumor, the method comprising a step of removing an amount of the interstitial fluid from said skin tumor with the interstitial fluid removal device according to claim 1 .

13. An interstitial fluid removal system, comprising a patch member which includes at least two recesses and at least two interstitial fluid removal devices according to claim 1 , a first one of said at least two interstitial fluid removal devices being arranged in a first recess of said at least two recesses.

14. The interstitial fluid removal system according to claim 13 , wherein a penetration depth of the first one of the at least two interstitial fluid removal devices arranged in the first recess of said at least two recesses differs from a penetration depth of a second one of the interstitial fluid removal devices arranged in a second recess of said at least two recesses.

15. A method for treating a subject with skin tumor, the method comprising a step of removing an amount of the interstitial fluid from said skin tumor with the interstitial fluid removal system according to claim 12 .

16. A method for manufacturing the interstitial fluid removal system according to claim 13 , comprising the steps of:

providing a 3D clinical representation of a skin tumor of a patient;

designing the patch member based on said clinical representation, the patch member having the at least two recesses;

providing at least two housings;

placing a first one of the at least two housings in the first recess of the at least two recesses, the first one of the at least two housings comprising the first needle and the second needle, wherein at least lengths of the first needle and the second needle are based on said clinical representation;

fluidly coupling the first needle of the first one of the at least two housings to one or more fluid injectors; and

fluidly coupling the second needle of the first one of the at least two housings to one or more interstitial fluid extractors.

17. The method according to claim 16 , wherein the two recesses of the at least two recesses have a different depth.

18. An interstitial fluid removal device comprising a first needle, a second needle, a fluid injector and an interstitial fluid extractor,

the first needle being configured for insertion in a tissue of a multicellular organism to provide a fluid inlet channel;

the second needle being configured for insertion in a tissue of a multicellular organism to provide an interstitial fluid outlet channel;

the fluid injector being arranged in fluid communication with both a fluid source and the first needle and configured to inject a fluid in the tissue of the multicellular organism; and

the interstitial fluid extractor being arranged in fluid communication with the second needle and configured to extract interstitial fluid from the tissue of the multicellular organism,

wherein the fluid injector and the interstitial fluid extractor are simultaneously operable,

wherein a distance between a needle tip of the first needle and a needle tip of the second needle is smaller than 3 mm, and

wherein an opening of the needle tip of the first needle and an opening of the needle tip of the second needle face towards each other.

19. An interstitial fluid removal system, comprising a patch member, which includes at least two recesses and at least two interstitial fluid removal devices according to claim 18 , a first one of said at least two interstitial fluid removal devices being arranged in a first recess of said at least two recesses.

20. A method for treating a subject with skin tumor, the method comprising a step of removing an amount of the interstitial fluid from said skin tumor with the interstitial fluid removal device according to claim 18 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2022
From: MOTTA, ALEXANDRE CHARLES ROGER; THAKOERSING, VARSHA SAKINA; ORANJE, RICHARDUS PAULUS ANTON
To: IMCOMET B.V.
Reel/Frame 060306/0452 →
Priority Claims (1)
NL 2024277 · Nov 21, 2019 · national
Continuity (1)
Related Publication 20220395258A1 · Dec 15, 2022
References Cited (62)
US 6132755A · Eicher · 2000 [cited by examiner]
US 6398931B1 · Burchette · 2002 [cited by examiner]
US 6652720B1 · Mansouri · 2003 [cited by examiner]
US 7344499B1 · Prausnitz · 2008 [cited by examiner]
US 9987427B1 · Polsky et al. · 2018 [cited by applicant]
US 10638963B2 · Beyerlein · 2020 [cited by examiner]
US 11060989B2 · Hanson · 2021 [cited by examiner]
US 11766203B2 · Miller · 2023 [cited by examiner]
US 20020188185A1 · Sohrab · 2002 [cited by examiner]
US 20040034318A1 · Fritz · 2004 [cited by examiner]
US 20040127929A1 · Roe · 2004 [cited by examiner]
US 20040176732A1 · Frazier · 2004 [cited by examiner]
US 20050113739A1 · Stiene · 2005 [cited by examiner]
US 20050177071A1 · Nakayama · 2005 [cited by examiner]
US 20070158212A1 · Filanovsky · 2007 [cited by examiner]
US 20070191696A1 · Mischler · 2007 [cited by examiner]
US 20070270672A1 · Hayter · 2007 [cited by examiner]
US 20080221408A1 · Hoarau · 2008 [cited by examiner]
US 20080234562A1 · Jina · 2008 [cited by examiner]
US 20090036795A1 · Duineveld · 2009 [cited by examiner]
US 20100056989A1 · McKay · 2010 [cited by examiner]
US 20100256524A1 · Levinson · 2010 [cited by examiner]
US 20110105942A1 · Lim · 2011 [cited by examiner]
US 20110172559A1 · Fei · 2011 [cited by examiner]
US 20110224515A1 · Mir · 2011 [cited by examiner]
US 20110264048A1 · O'Dea · 2011 [cited by examiner]
US 20120277697A1 · Haghgooie · 2012 [cited by examiner]
US 20130158468A1 · Bernstein · 2013 [cited by examiner]
US 20130211289A1 · Moga · 2013 [cited by examiner]
US 20130253289A1 · Hadvary · 2013 [cited by examiner]
US 20130263997A1 · Down · 2013 [cited by examiner]
US 20130306155A1 · Mathus · 2013 [cited by examiner]
US 20130317391A1 · Bullington · 2013 [cited by examiner]
US 20140114279A1 · Klinghoffer · 2014 [cited by examiner]
US 20140148669A1 · Garcia Saban · 2014 [cited by examiner]
US 20150201877A1 · Gasparyan · 2015 [cited by examiner]
US 20150202418A1 · Simon · 2015 [cited by examiner]
US 20150208984A1 · Huang · 2015 [cited by examiner]
US 20160029937A1 · Sia · 2016 [cited by examiner]
US 20160051981A1 · Berthier · 2016 [cited by examiner]
US 20160166185A1 · Liepmann · 2016 [cited by examiner]
US 20160296149A1 · Polsky · 2016 [cited by examiner]
US 20170023546A1 · Holmes · 2017 [cited by examiner]
US 20170080164A1 · Kwon · 2017 [cited by examiner]
US 20170122846A1 · Holmes · 2017 [cited by examiner]
US 20170164933A1 · Coats · 2017 [cited by examiner]
US 20170172481A1 · Berthier · 2017 [cited by examiner]
US 20170304553A1 · Bender · 2017 [cited by examiner]
US 20180070869A1 · Ionescu · 2018 [cited by examiner]
US 20180161563A1 · Renlund · 2018 [cited by examiner]
US 20180256086A1 · Polsky · 2018 [cited by examiner]
US 20180264043A1 · Pettine · 2018 [cited by examiner]
US 20180338713A1 · Polsky · 2018 [cited by examiner]
US 20200230388A1 · Daniele · 2020 [cited by examiner]
US 20220240815A1 · Chae · 2022 [cited by examiner]
US 20220322981A1 · Chae · 2022 [cited by examiner]
WO 2005000382A2 · 2005 [cited by applicant]
WO 2010122222A2 · 2010 [cited by applicant]
WO 2014093934A1 · 2014 [cited by applicant]
WO 2016164208A1 · 2016 [cited by applicant]
International Search Report (ISR) for PCT/NL2020/050723 mailed Feb. 2, 2021 (5 pages). [cited by applicant]
Written Opinion for PCT/NL2020/050723 mailed Feb. 2, 2021 (7 pages). [cited by applicant]